dipyridamole has been researched along with phosphorus radioisotopes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bottaro, T; Cordì, GC; Gaggero, E; Motta, A; Venzano, C | 1 |
| Berk, PD; Goldberg, JD; Tartaglia, AP; Wasserman, LR | 1 |
| Gastpar, H | 1 |
1 review(s) available for dipyridamole and phosphorus radioisotopes
| Article | Year |
|---|---|
[Modification of metastasis formation by inhibition of platelet aggregation. Experimental and clinical results].
Topics: Animals; Bencyclane; Cell Adhesion; Cells, Cultured; Dipyridamole; Humans; Lymphocytes; Mice; Mopidamol; Neoplasm Metastasis; Pentoxifylline; Phosphorus Radioisotopes; Platelet Aggregation; Pyrazoles; Pyrazolones; Pyrimidines; Rats | 1983 |
2 other study(ies) available for dipyridamole and phosphorus radioisotopes
| Article | Year |
|---|---|
[Essential thrombocythemia. Case reports and clinico-therapeutic considerations].
Topics: Alkylating Agents; Antimetabolites; Aspirin; Bone Marrow; Dipyridamole; Drug Therapy, Combination; Humans; Phosphorus Radioisotopes; Platelet Count; Remission Induction; Thrombocythemia, Essential | 1990 |
Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera.
Topics: Aspirin; Dipyridamole; Female; Hemorrhage; Humans; Male; Phosphorus Radioisotopes; Platelet Aggregation; Platelet Count; Polycythemia Vera; Thrombosis | 1986 |